Longevity & Aging · Gut & Microbiome
Bacteroides ovatus (and its metabolite lysophosphatidylcholine) is depleted in Alzheimer's and supplementation reduces amyloid and rescues cognition in Alzheimer's mouse models
In plain terms: Does restoring the gut bacterium Bacteroides ovatus reduce Alzheimer's pathology (shown in mice)?
A single 2025 Cell Metabolism study showed supplementing B. ovatus (or its LPC metabolite) cut amyloid and improved cognition in 5xFAD mice via GPR119/anti-ferroptosis; independent FMT and gut-microbiota work supports a real gut-to-Alzheimer's axis at the genus level, which nudges this to weak support — but no independent group has tested B. ovatus itself against AD endpoints, and one study even found Bacteroides worsening amyloid, so it stays preliminary.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Animal studies (Animal)
How the studies fall
What the evidence shows
<!-- vault-context --> Norwitz **affirms** this claim. Consensus below reflects independent literature only.
The evidence (8)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Chen 2022 · Gut | animal | mixed | moderate | Gut dysbiosis drove PUFA-associated neuroinflammation and AD pathology in mice; supports a causal gut-AD axis but does not identify B. ovatus as protective. |
| 2024 venue: Curr Alzheimer Res · Curr Alzheimer Res | observational | mixed | low | Gut-microbiota disruptions associate with preclinical AD cognitive deficit; supports microbiome-AD link broadly, no B. ovatus-specific rescue. |
| Zha 2025 · Cell Metab | animal | supports | moderate | Cited paper verified: Bacteroides depleted/Clostridium raised in 5xFAD; B. ovatus or LPC reduces Abeta & rescues cognition via GPR119->ACSL4->suppressed ferroptosis; AD human fecal/serum B.ovatus & LPC low. Mechanism is GPR119/ferroptosis, NOT MFSD2A/NRF2. |
| 2025 venue: Biomolecules · Biomolecules | observational | mixed | low | Gut microbial composition/SCFA in cognitively unimpaired adults; general microbiome-cognition context only, not B. ovatus rescue. |
| Cox 2019 · Scientific Reports | animal | contradicts | moderate | In Tg2576 AD mice, age-related Bacteroides expansion tracked Abeta and gnotobiotic Bacteroides colonization exacerbated Abeta deposition, opposing the "Bacteroides is protective" direction. |
| Sun 2019 · Translational Psychiatry | animal | supports | moderate | FMT in APP/PS1 mice reduced Abeta deposition and tau phosphorylation and restored SCFAs/cognition (not B. ovatus-specific). |
| Kim 2020 · Gut | animal | supports | moderate | Transfer of healthy microbiota into ADLPAPT AD mice reduced amyloid and tau pathology and reversed dysbiosis (genus-level, not B. ovatus-specific). |
| Liu 2020 · Food Funct | animal | mixed | low | Fermented milk raised Bacteroides/Faecalibacterium abundance and reduced Abeta in APP/PS1 mice; correlational and whole-food confounded. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.